PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.17
ESG score 80-90% of RVPH's 66.75. Walter Schloss would scrutinize governance quality and regulatory exposure.
58.08
Environmental score below 80% of RVPH's 78.30. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
59.30
Similar social score to RVPH's 60.47. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
60.13
Similar governance score to RVPH's 61.49. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.